Researchers at Stanford University have created mice with brains composed of roughly half human nerve cells by implanting lab-grown organoids into rodents engineered to lack a cortex. Published in Nature on September 16, 2026, the breakthrough aims to model complex neurological disorders like cerebral palsy and frontotemporal dementia.
Human brain disorders remain notoriously difficult to study. The human brain contains roughly 86 billion neurons with trillions of connections, and living tissue is rarely accessible for research. For more than a decade, scientists have grown tiny, three-dimensional replicas called organoids from reprogrammed human skin cells to bridge that gap. But in laboratory dishes, these cell clusters lack the sensory inputs and complex wiring of a living nervous system. Past attempts to transplant organoids into rat brains hit a biological roadblock because rodent tissue grew faster than the human cells, leaving little room for expansion.
Genetically Engineering Mice for Human Brain Tissue
To solve the spatial limitation, a research team led by Sergiu Pașca at Stanford University genetically modified mice so they would not develop their cerebral cortex and hippocampus—two vital brain regions governing movement, learning, and memory that make up about half of the brain’s total volume. When the rodents were two days old, researchers injected human brain organoids into the empty cavities. Each injection contained roughly 100,000 human-derived cells. The transplantation successfully took hold in 25 of 29 attempts, as Science News reports.
Three months after the surgery, the human tissue expanded nearly fivefold in volume. The transplanted cells hooked up to the mouse’s blood supply, integrated into the neural wiring, and almost entirely filled the cavity, taking up over 90 percent of the cortical area.
Behavioral Tests and Unexpected Cellular Discoveries
Despite possessing brains that are half human by volume, the animals showed no signs of cognitive enhancement. During standard tests, the grafted mice performed similarly to control creatures, though mice missing part of their cortex displayed a more cautious gait and mild memory problems compared to normal animals. Our goal has been to make aspects of human brain development and function accessible for investigation, so we can develop therapeutics,
said Sergiu Pașca, a neuroscientist at Stanford University.
Researchers also discovered that some of the human-derived tissue matured into cells known as von Economo neurons. These specialized cells have only been seen in postmortem examinations, and scientists have been unable to grow them previously in laboratory dishes. Because von Economo neurons are among the first cells to degenerate in frontotemporal dementia, the hybrid mouse model provides a living platform to investigate why these specific cells exhibit unique susceptibility to neurodegenerative disease.
Modeling Complex Human Diseases in Rodents
The hybrid model also opens new avenues for studying conditions like cerebral palsy. Because normal mice resist oxygen deprivation in ways humans do not, researchers subjected the xenocortical mice to low oxygen levels. Following the deprivation, the human tissue displayed cellular signs of injury, and the mice developed motor coordination and gait issues that mimic cerebral palsy symptoms in humans. Investigators plan to use the modified rodents to screen therapeutic candidates for cerebral palsy, genetic forms of autism, and epilepsy.
“”
Sergiu Pasca, lead researcher at Stanford University
Weighing the Ethical Boundaries of Neural Xenotransplantation
The creation of animals with partial human brain tissue has drawn scrutiny from bioethicists regarding animal welfare and the moral status of altered cognitive capacities.
Other scientists emphasize that strict regulatory frameworks must accompany future research.